PRESS RELEASE published on 05/03/2023 at 07:00, 2 years 7 months ago Straumann Group achieved CHF 596 million revenue in the first quarter and launched advanced digital solutions
PRESS RELEASE published on 04/19/2023 at 15:00, 2 years 7 months ago Invitation: Straumann Group 2023 first-quarter sales report webcast
PRESS RELEASE published on 04/05/2023 at 13:55, 2 years 7 months ago Straumann Group shareholders approve all proposals and elect Dr. Olivier Filliol as a new Board Member
PRESS RELEASE published on 03/14/2023 at 07:00, 2 years 8 months ago Straumann Group launches digital solutions for dentistry at International Dental Show (IDS) in Cologne
PRESS RELEASE published on 02/21/2023 at 07:00, 2 years 9 months ago Straumann Group grew 15.7% organically in 2022
PRESS RELEASE published on 02/09/2023 at 16:18, 2 years 9 months ago Invitation: Straumann Group 2022 full-year results webcast
PRESS RELEASE published on 01/04/2023 at 07:00, 2 years 11 months ago Straumann Group appoints interim Chief Financial Officer
Published on 12/05/2025 at 02:35, 3 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 9 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 40 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
